Medipal Holdings Stock Performance

MEPDF Stock  USD 19.00  0.00  0.00%   
On a scale of 0 to 100, MediPal Holdings holds a performance score of 9. The company secures a Beta (Market Risk) of 0.2, which conveys not very significant fluctuations relative to the market. As returns on the market increase, MediPal Holdings' returns are expected to increase less than the market. However, during the bear market, the loss of holding MediPal Holdings is expected to be smaller as well. Please check MediPal Holdings' variance, as well as the relationship between the maximum drawdown and rate of daily change , to make a quick decision on whether MediPal Holdings' current price movements will revert.

Risk-Adjusted Performance

Fair

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in MediPal Holdings are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile fundamental indicators, MediPal Holdings reported solid returns over the last few months and may actually be approaching a breakup point. ...more
Begin Period Cash Flow240 B
Total Cashflows From Investing Activities-24.3 B
  

MediPal Holdings Relative Risk vs. Return Landscape

If you would invest  1,650  in MediPal Holdings on November 10, 2025 and sell it today you would earn a total of  250.00  from holding MediPal Holdings or generate 15.15% return on investment over 90 days. MediPal Holdings is currently producing 0.2367% returns and takes up 1.8939% volatility of returns over 90 trading days. Put another way, 17% of traded pink sheets are less volatile than MediPal, and 96% of all traded equity instruments are likely to generate higher returns over the next 90 trading days.
  Expected Return   
       Risk  
Assuming the 90 days horizon MediPal Holdings is expected to generate 2.33 times more return on investment than the market. However, the company is 2.33 times more volatile than its market benchmark. It trades about 0.12 of its potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.12 per unit of risk.

MediPal Holdings Target Price Odds to finish over Current Price

The tendency of MediPal Pink Sheet price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 19.00 90 days 19.00 
near 1
Based on a normal probability distribution, the odds of MediPal Holdings to move above the current price in 90 days from now is near 1 (This MediPal Holdings probability density function shows the probability of MediPal Pink Sheet to fall within a particular range of prices over 90 days) .
Assuming the 90 days horizon MediPal Holdings has a beta of 0.2. This indicates as returns on the market go up, MediPal Holdings average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding MediPal Holdings will be expected to be much smaller as well. Additionally MediPal Holdings has an alpha of 0.2039, implying that it can generate a 0.2 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).
   MediPal Holdings Price Density   
       Price  

Predictive Modules for MediPal Holdings

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as MediPal Holdings. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of MediPal Holdings' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
17.1119.0020.89
Details
Intrinsic
Valuation
LowRealHigh
17.7719.6621.55
Details

MediPal Holdings Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. MediPal Holdings is not an exception. The market had few large corrections towards the MediPal Holdings' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold MediPal Holdings, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of MediPal Holdings within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
0.20
β
Beta against Dow Jones0.20
σ
Overall volatility
0.90
Ir
Information ratio 0.08

MediPal Holdings Fundamentals Growth

MediPal Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of MediPal Holdings, and MediPal Holdings fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on MediPal Pink Sheet performance.

About MediPal Holdings Performance

By analyzing MediPal Holdings' fundamental ratios, stakeholders can gain valuable insights into MediPal Holdings' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if MediPal Holdings has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if MediPal Holdings has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Medipal Holdings Corporation engages in the prescription pharmaceutical wholesale business in Japan. Medipal Holdings Corporation was founded in 1898 and is headquartered in Tokyo, Japan. MEDIPAL HOLDINGS operates under Medical Distribution classification in the United States and is traded on OTC Exchange. It employs 12801 people.

Things to note about MediPal Holdings performance evaluation

Checking the ongoing alerts about MediPal Holdings for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for MediPal Holdings help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Evaluating MediPal Holdings' performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate MediPal Holdings' pink sheet performance include:
  • Analyzing MediPal Holdings' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether MediPal Holdings' stock is overvalued or undervalued compared to its peers.
  • Examining MediPal Holdings' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating MediPal Holdings' management team can have a significant impact on its success or failure. Reviewing the track record and experience of MediPal Holdings' management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of MediPal Holdings' pink sheet. These opinions can provide insight into MediPal Holdings' potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating MediPal Holdings' pink sheet performance is not an exact science, and many factors can impact MediPal Holdings' pink sheet market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Complementary Tools for MediPal Pink Sheet analysis

When running MediPal Holdings' price analysis, check to measure MediPal Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MediPal Holdings is operating at the current time. Most of MediPal Holdings' value examination focuses on studying past and present price action to predict the probability of MediPal Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MediPal Holdings' price. Additionally, you may evaluate how the addition of MediPal Holdings to your portfolios can decrease your overall portfolio volatility.
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Fundamental Analysis
View fundamental data based on most recent published financial statements
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets